Cargando…

Spectral domain optical coherence tomography evaluation of macular changes in Eales disease

PURPOSE: The purpose of the study was to describe macular changes in treatment-naïve eyes with Eales disease using spectral domain optical coherence tomography (SD-OCT). METHODS: A cross-sectional study was done on 79 eyes of 66 patients with Eales disease. Best-corrected visual acuity (BCVA), slit-...

Descripción completa

Detalles Bibliográficos
Autores principales: Goel, Neha, Kumar, Vinod, Arora, Supriya, Jain, Pooja, Ghosh, Basudeb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859602/
https://www.ncbi.nlm.nih.gov/pubmed/29480258
http://dx.doi.org/10.4103/ijo.IJO_845_17
_version_ 1783307852697305088
author Goel, Neha
Kumar, Vinod
Arora, Supriya
Jain, Pooja
Ghosh, Basudeb
author_facet Goel, Neha
Kumar, Vinod
Arora, Supriya
Jain, Pooja
Ghosh, Basudeb
author_sort Goel, Neha
collection PubMed
description PURPOSE: The purpose of the study was to describe macular changes in treatment-naïve eyes with Eales disease using spectral domain optical coherence tomography (SD-OCT). METHODS: A cross-sectional study was done on 79 eyes of 66 patients with Eales disease. Best-corrected visual acuity (BCVA), slit-lamp biomicroscopy (SLB), indirect ophthalmoscopy, fundus fluorescein angiography (FFA), and quantitative (central macular thickness [CMT]) and qualitative analysis on SD-OCT were performed. RESULTS: Forty-six (58.2%) eyes had macular involvement as assessed with SD-OCT, while in 33 (41.8%) eyes, macula was not affected. Macular edema was the most common feature when macula was affected followed by epiretinal membrane. Mean CMT was higher (315.3 ± 102.3 μm) in eyes with macular involvement than those without it (243.8 ± 19.3 μm). Eyes with active vasculitis involving larger vessels and neovascularization had greater chance of macular involvement. SLB and FFA alone missed 28.3% and 50% eyes with macular abnormalities on SD-OCT, respectively. CONCLUSION: While the clinical description of Eales disease points mainly to a peripheral location, macular involvement can be commonly picked up when SD-OCT is used. Macular involvement when present is associated with a poorer BCVA.
format Online
Article
Text
id pubmed-5859602
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58596022018-03-23 Spectral domain optical coherence tomography evaluation of macular changes in Eales disease Goel, Neha Kumar, Vinod Arora, Supriya Jain, Pooja Ghosh, Basudeb Indian J Ophthalmol Original Article PURPOSE: The purpose of the study was to describe macular changes in treatment-naïve eyes with Eales disease using spectral domain optical coherence tomography (SD-OCT). METHODS: A cross-sectional study was done on 79 eyes of 66 patients with Eales disease. Best-corrected visual acuity (BCVA), slit-lamp biomicroscopy (SLB), indirect ophthalmoscopy, fundus fluorescein angiography (FFA), and quantitative (central macular thickness [CMT]) and qualitative analysis on SD-OCT were performed. RESULTS: Forty-six (58.2%) eyes had macular involvement as assessed with SD-OCT, while in 33 (41.8%) eyes, macula was not affected. Macular edema was the most common feature when macula was affected followed by epiretinal membrane. Mean CMT was higher (315.3 ± 102.3 μm) in eyes with macular involvement than those without it (243.8 ± 19.3 μm). Eyes with active vasculitis involving larger vessels and neovascularization had greater chance of macular involvement. SLB and FFA alone missed 28.3% and 50% eyes with macular abnormalities on SD-OCT, respectively. CONCLUSION: While the clinical description of Eales disease points mainly to a peripheral location, macular involvement can be commonly picked up when SD-OCT is used. Macular involvement when present is associated with a poorer BCVA. Medknow Publications & Media Pvt Ltd 2018-03 /pmc/articles/PMC5859602/ /pubmed/29480258 http://dx.doi.org/10.4103/ijo.IJO_845_17 Text en Copyright: © 2018 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Goel, Neha
Kumar, Vinod
Arora, Supriya
Jain, Pooja
Ghosh, Basudeb
Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
title Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
title_full Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
title_fullStr Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
title_full_unstemmed Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
title_short Spectral domain optical coherence tomography evaluation of macular changes in Eales disease
title_sort spectral domain optical coherence tomography evaluation of macular changes in eales disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859602/
https://www.ncbi.nlm.nih.gov/pubmed/29480258
http://dx.doi.org/10.4103/ijo.IJO_845_17
work_keys_str_mv AT goelneha spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease
AT kumarvinod spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease
AT arorasupriya spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease
AT jainpooja spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease
AT ghoshbasudeb spectraldomainopticalcoherencetomographyevaluationofmacularchangesinealesdisease